Tuesday, February 08, 2022 12:05:20 PM
Digirad, the largest dedicated cardiac SPECT manufacturer's blog provides the most succinct description of why Fluorpiridaz is going to create a sea change from SPECT to PET for non-invasive cardiac imaging:
https://www.digirad.com/flurpiridaz-change-cardiac-pet-imaging/
When the incumbent provides that rosy of an outlook for the coming disruption, you have to respect their intellectual honesty and the said advantages the new technology will bring!
The trial completion is expected in April 2022:
https://clinicaltrials.gov/ct2/show/NCT03354273
WVU indicates the trial enrollment is closed, so it seems to be on schedule:
https://wvumedicine.org/heart/clinical-research/clinical-trials/
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM